The success of Sildenafil initially sparked a surge for pharma, nevertheless recent changes present a murky picture for shareholders. Generic competitors are eating into earnings, and continued litigation add https://zubairmstu583649.blogscribble.com/41429101/viagra-and-pharma-a-risky-play